全文获取类型
收费全文 | 667082篇 |
免费 | 76092篇 |
国内免费 | 311篇 |
出版年
2018年 | 5788篇 |
2016年 | 7721篇 |
2015年 | 10202篇 |
2014年 | 12134篇 |
2013年 | 16835篇 |
2012年 | 19059篇 |
2011年 | 19671篇 |
2010年 | 13311篇 |
2009年 | 12541篇 |
2008年 | 17890篇 |
2007年 | 18542篇 |
2006年 | 17666篇 |
2005年 | 16897篇 |
2004年 | 16795篇 |
2003年 | 16058篇 |
2002年 | 15710篇 |
2001年 | 31395篇 |
2000年 | 31548篇 |
1999年 | 24746篇 |
1998年 | 8214篇 |
1997年 | 8649篇 |
1996年 | 8058篇 |
1995年 | 7467篇 |
1994年 | 7332篇 |
1993年 | 7520篇 |
1992年 | 20171篇 |
1991年 | 20050篇 |
1990年 | 19376篇 |
1989年 | 18888篇 |
1988年 | 17975篇 |
1987年 | 17029篇 |
1986年 | 15686篇 |
1985年 | 15454篇 |
1984年 | 12621篇 |
1983年 | 10954篇 |
1982年 | 8205篇 |
1981年 | 7314篇 |
1980年 | 7045篇 |
1979年 | 11946篇 |
1978年 | 9339篇 |
1977年 | 8556篇 |
1976年 | 7977篇 |
1975年 | 8816篇 |
1974年 | 9687篇 |
1973年 | 9492篇 |
1972年 | 8680篇 |
1971年 | 7959篇 |
1970年 | 7040篇 |
1969年 | 6923篇 |
1968年 | 6454篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
951.
952.
953.
The role of asialo GM1+ (ASGM1+) cells and exogenous IL-2 in the age-related decline in allospecific CTL activity was evaluated. Primary CTL were generated in mixed leukocyte culture (MLC) [BALB/cANN (H-2d) anti C57BL/6N (H-2b)] and tested for allospecific lytic activity against the EL-4 (H-2b) cell culture line, and for non-MHC-restricted activity against WEHI-3 (H-2d) and YAC-1 (H-2a). Cultures included responder cell populations which had been treated with antibody to ASGM1 plus complement or complement alone, and irradiated stimulator cells, in the presence or absence of rIL-2 or crude IL-2-containing supernatants. The amount of rIL-2 used to accommodate the age-related decline in IL-2 production was determined empirically to be 500 U by assessing IL-2 production in MLCs containing responder cells from young versus old animals. rIL-2 appeared to restore the allospecific CTL activity generated by spleen cells of old mice to the level of that of young. However, treatment with anti-ASGM1 antibody revealed that this restoration was due to an effect of the IL-2 on ASGM1+ cells. The allospecific target cells, EL-4, were not sensitive to lymphokine-activated killer (LAK) cells induced by IL-2 alone under the conditions used. It is suggested that the apparent restoration was due to increased LAK-like (or MHC-nonrestricted) activity mediated by an ASGM1+ cell in the CTL precursor population. 相似文献
954.
Retrovirus-mediated immunosuppression. II. FeLV-UV alters in vitro murine T lymphocyte behavior by reversibly impairing lymphokine secretion 总被引:5,自引:0,他引:5
C G Orosz N E Zinn R G Olsen L E Mathes 《Journal of immunology (Baltimore, Md. : 1950)》1985,135(1):583-590
Murine splenocytes and cloned murine T cells were used to study the in vitro immunosuppressive effects of UV-inactivated feline leukemia virus (FeLV-UV) on lymphokine secretion. FeLV-UV can significantly depress the accumulation of IL 2 in cultures of Con A-stimulated C57BL/6 splenocytes and in cultures containing the alloreactive helper T cell clone B6D/2-2m plus Con A. Inhibition of lymphokine accumulation in these cultures could not be attributed to absorption or inactivation of IL 2 by the FeLV-UV or to the FeLV-UV-induced production of substances which interfere with the IL 2 bioassay. Thus, FeLV-UV appears to block production and/or secretion of IL 2 by a direct inhibitory effect on IL 2-secreting murine T lymphocytes. Additional studies indicate that FeLV-UV impairs IL 2 production only if added very soon after lymphocyte contact with lymphokine-inducing agents and that IL 2 secretion resumes when FeLV-UV is removed from the culture. FeLV-UV also impairs accumulation of MAF (interferon-gamma?) in cultures of Con A-stimulated C57BL/6 splenocytes and in cultures containing the alloreactive cytotoxic T lymphocyte clone B6D/2-7c plus Con A. The latter observation again suggests that FeLV-UV impairs lymphokine secretion by a direct effect on lymphokine-producing T lymphocytes. Furthermore, it suggests that FeLV-UV does not selectively impair production of IL 2 nor does it have selective inhibitory effects on helper T cells. Rather, FeLV-UV appears to have a general inhibitory effect on lymphokine production by T lymphocytes. Finally, concentrations of FeLV-UV which suppress MAF production by the CTL clone have little influence on the cytolysis mediated by the same cloned T cell population. Thus, the immunosuppressive influence of FeLV-UV is selective for phenomena associated with induction of new T lymphocyte functions, such as lymphokine secretion, and spares other immune functions already expressed by the same cells. 相似文献
955.
The non-recombining nature of the Y-chromosome determines the non-independence of alleles between loci. The evolution of short tandem repeat (STR) loci in the Y-chromosome is the result of different factors such as differential mutation rates, mutation modes, gene conversion, selection and demographic processes. The degree of correlation between loci is dependent on the magnitude of these processes. The simulation of data is a routine tool used for testing hypotheses in population and evolutionary studies. The most basic parameters hitherto used in lineage haplotype simulations are the allele frequency distributions and mutation rates, assuming either full independence or linkage between loci. In this study we introduce use of the Spearman correlation coefficient to estimate the degree of dependence between non-recombining loci. Then, both the interdependence between loci and the allele frequency distributions at multi-allelic loci are incorporated in an algorithm for simulating haplotypes. We illustrate the method using published and unpublished Y-chromosome STR data. 相似文献
956.
957.
958.
Glycogen debranching enzyme: purification, antibody characterization, and immunoblot analyses of type III glycogen storage disease. 总被引:2,自引:1,他引:1
下载免费PDF全文
![点击此处可从《American journal of human genetics》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Type III glycogen storage disease is caused by a deficiency of glycogen debranching-enzyme activity. Many patients with this disease have both liver and muscle involvement, whereas others have only liver involvement without clinical or laboratory evidence of myopathy. To improve our understanding of the molecular basis of the disease, debranching enzyme was purified 238-fold from porcine skeletal muscle. In sodium dodecyl sulfate-polyacrylamide gel electrophoresis the purified enzyme gave a single band with a relative molecular weight of 160,000 that migrated to the same position as purified rabbit-muscle debranching enzyme. Antiserum against porcine debranching enzyme was prepared in rabbit. The antiserum reacted against porcine debranching enzyme with a single precipitin line and demonstrated a reaction having complete identity to those of both the enzyme present in crude muscle and the enzyme present in liver extracts. Incubation of antiserum with purified porcine debranching enzyme inhibited almost all enzyme activity, whereas such treatment with preimmune serum had little effect. The antiserum also inhibited debranching-enzyme activity in crude liver extracts from both pigs and humans to the same extent as was observed in muscle. Immunoblot analysis probed with anti-porcine-muscle debranching-enzyme antiserum showed that the antiserum can detect debranching enzyme in both human muscle and human liver. The bands detected in human samples by the antiserum were the same size as the one detected in porcine muscle. Five patients with Type III and six patients with other types of glycogen storage disease were subjected to immunoblot analysis. Although anti-porcine antiserum detected specific bands in all liver and muscle samples from patients with other types of glycogen storage disease (Types I, II, and IX), the antiserum detected no cross-reactive material in any of the liver or muscle samples from patients with Type III glycogen storage disease. These data indicate (1) immunochemical similarity of debranching enzyme in liver and muscle and (2) that deficiency of debranching-enzyme activity in Type III glycogen storage disease is due to absence of debrancher protein in the patients that we studied. 相似文献
959.
Characterization of a novel kinetochore protein, CENP-H. 总被引:11,自引:0,他引:11
960.
E. B. Naimark 《Paleontological Journal》2014,48(2):166-176
The validity of Eurudagnostus Lermontova, 1951 was confirmed by reexamination of the collection from the Boshe-Kul’ core. The diagnoses of genera of Agnostidae were reviewed, and Eurudagnostus falls well within the concept of the family Agnostidae. The diagnostic features of Eurudagnostus include a delicate border furrows, the transglabellar furrow bent posteriad or straight, short pygidial axis, incomplete transaxial F1, absent or very poorly developed median preglabellar furrow, and absent lanceolate field on the posteroaxis. Following revision the genus comprises 12 valid species, including some species and varieties previously assigned to other genera. ?Eurudagnostus brevispinus Lermontova, 1951 is synonymized with E. chiushuensis (Kobayashi, 1931). Two species, E. chiushuensis and ?E. intermedius (Palmer, 1968) appeared to have inter-continental distribution in the Cambrian-Ordovician beds, and E. mutabilis (Ergaliev, 1980) is also more widely distributed than previously recognized. 相似文献